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Abstract
Most patients with bowel cancer are symptomatic at the time of the diagnosis. They may present with a
change in bowel habit, bleeding per rectum, abdominal pain, anaemia, weight loss or bowel obstruction.
Colonic carcinoma can also be diagnosed incidentally during screening programs. Moreover, it may be
incidentally detected in CT scans being performed for other indications or encountered during surgery for
other causes. Some patients with colonic bowel ischaemia have associated large bowel cancer, where the
ischaemic segment is usually proximal to the tumour and not necessarily associated with bowel obstruction.
We are presenting a rare case of incidental malignant colonic polyp detected in a resected ischaemic large
bowel in an 88-year-old gentleman. This was a very small tumour that was not visible macroscopically or
detectable by imaging. Pathological examination of non-tumour colorectal resection specimens, as in this
case, should include careful macroscopic examination and sequential block selection along the length of the
colon, and where there is diffuse mucosal abnormality, block selection at 100mm interval is also advised.
Attention to and block selection from any suspicious-looking area is warranted in all cases of non-tumour
colorectal resections if such microscopic-sized malignancies of the type seen in our patient are to be picked
up.
Categories: Pathology, Radiology, General Surgery
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Introduction
Colonic malignancy occupies fourth place among the most common cancers in the UK and is regarded as the
second most frequent cause of cancer-related mortality. Every year, more than 42,000 new cases are
diagnosed, and currently around 268,000 people are living with colonic cancer in the UK. The diagnosis of
colonic cancer is usually made by histological examination of a biopsy that is gotten during colonoscopy or
from a surgical specimen, with the vast majority of tumours of the colon being carcinomas. Of the
carcinomas, more than 90% are adenocarcinomas [1]. Incidental colorectal carcinoma is defined as a
clinically inapparent carcinoma of the large intestine diagnosed or discovered unexpectedly. It can be
detected in imaging for other reasons [2], during colonoscopy bowel cancer screening [3], during surgical
intervention for unrelated causes, as well as in autopsy. In this case, it was discovered during pathologic
examination of a subtotal colectomy specimen removed for ischaemic colitis. The prevalence of incidentally
discovered colon carcinoma, as well as the molecular patterns of these incidental tumours in the UK, is
underreported, and as such its importance in the evaluation of the incidence and future trends of colon
cancers is currently unknown.
Case Presentation
An 88-year-old male presented with a recent history of acute abdominal pain and vomiting. His past medical
history included ischaemic heart disease, cerebrovascular accident and an open repair of abdominal aortic
aneurysm 10 years earlier, in addition to an unoperated incisional hernia. On examination, the patient was
septic and in cardiogenic shock. Urgent CT abdomen and pelvis showed free intra-abdominal air (Figure 1),
thickened descending and proximal sigmoid colon with locules of transmural air, as well as locules of extra-
luminal gas around it, and this was thought to be the site of the perforation. Because of the presence of
aortobiiliac stent within the abdominal aortic aneurysm, origin of the inferior mesenteric artery could not be
delineated. However normally opacified tributaries of inferior mesenteric artery supplying the sigmoid and
descending colon via collaterals were demonstrated (Figures 2, 3, 4). The patient had undergone an
emergency laparotomy, adhesiolysis and subtotal colectomy with an end ileostomy. Intra-operative findings
included friable large bowel from mid-sigmoid to caecum with a widespread ischaemic appearance and
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multiple perforations. Postoperatively, the patient required intensive care unit admission, and
unfortunately, he died a week later due to sepsis and multiple organ failure.
FIGURE 1: CT abdomen axial view shows free intra-peritoneal air (yellow
arrow)
FIGURE 2: Abdominal contrast-enhanced coronal images demonstrates
circumferential thickening of the descending colon with peri colonic fat
stranding (A) and evidence of a few extra luminal gas locules
suggesting possible site of perforation as indicated by blue arrows
(A&B). There are multiple contrast-enhancing rounded structures in the
root of mesentery, they represent aortobiiliac stent within the abdominal
aortic aneurysm.
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FIGURE 3: Contrast-enhanced sagittal image demonstrates diffuse
circumferential thickening of the descending and proximal sigmoid
colon with associated pericolonic fat stranding, in keeping with ongoing
colitis. Considering the limitation due to unprepared CT scan for bowel
loops evaluation, possible small intraluminal sinister polyp or mass
cannot be excluded.
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FIGURE 4: Contrast-enhanced sagittal image with magnified view
demonstrates gas locules within the bowel loop wall in keeping with
pneumatosis intestinalis, which is suggestive of ischaemic bowel.
Pathological examination of the resected bowel revealed colectomy with terminal ileum specimen; the
appendix was not identified. On opening the colon, there were extensive but patchy areas of mucosal
ulceration with elevated edges. The margins of the ulcers appeared elevated. A focus of colonic perforation
was identified. No tumours were identified macroscopically. The mucosa was extensively sampled
sequentially from the ileum through the distal colon to include both resection margins. Microscopic
examination of the ileum appeared normal, while sections from the large bowel showed extensive areas of
mucosal ulceration with features of transmural acute ischaemic necrosis and associated suppurative
serositis. Arteriosclerotic vascular changes in several blood vessels with some vessels showing marked
luminal narrowing supportive of ischaemic colitis are noted. A single 8mm polyp of mainly poorly
differentiated adenocarcinoma in addition to well-differentiated adenocarcinoma that had invaded into the
pericolic adipose tissue (pT3) was found in a single section from the ascending colon. The poorly
differentiated adenocarcinoma was present in both the mucosal surface and deeper layers of the colonic wall
beyond the muscularis propria (Figure 5A, 5B). The full extent of tumour invasion by the poorly
differentiated component was highlighted by pancytokeratin (MNF116) immunostaining (Figure 5C, 5D).
CDX2 was positive in the well-differentiated component of the tumour but uniformly negative in the poorly
differentiated aspect (Figure 6A). In the pericolic fat, the tumour cells were differentiated from macrophages
with CD68 that stained the macrophages (Figure 6B). The poorly differentiated component of the tumour in
our case showed negativity for CK7 uniformly. CK20 showed patchy positivity in the superficial well-
differentiated component but was uniformly negative in the poorly differentiated component. The primary
colonic origin of the adenocarcinoma, especially the poorly differentiated component, necessitated
immunostaining with CK7 (Figure 6C), which was negative. CK20, which is an epithelial marker
with restricted expression compared to CK7, revealed very occasional positive tumour cells in the well-
differentiated component (Figure 6D), but was uniformly negative in the poorly differentiated component
(Figure 6E). Special AT-rich sequence-binding protein 2 (SATB2), a useful new highly specific biomarker, is
expressed in 85% of all colorectal carcinomas. In combination with CK20, it identifies more than 95% of all
colorectal cancers; it is recommended in lower GI tumours due to its high specificity. The above
immunohistochemical pattern is consistent with the established practice from molecular studies that
colorectal cancer is a heterogeneous group of neoplastic diseases that develop through three main
pathogenetic pathways, namely the chromosomal instability pathway, the microsatellite instability (MSI)
pathway, and the CpG island methylation pathway. Clinicopathologic studies are also pointing to colorectal
carcinomas originating through these three pathways to differ in the type of precursor lesions, natural
history, and pathological features. The combination of CK20/CK7 immunoprofiles showed that the
CK20+/CK7− profile was the highest (60.4%), CK20−/CK7− was 35.4%, CK20+/CK7+ was 2.1% and
CK20−/CK7+ was 2.1%. CK20 is specific for colonic, urothelial and Merkel cell carcinoma. On the other hand,
CK7 is characteristic of glandular malignancies originating from the breast, respiratory tract, biliary tract
and Mullerian epithelium [4].
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FIGURE 5: A: H&E x10. pT3 (poorly differentiated sheet of tumour cells
infiltrating pericolic adipose tissue). B: H&E x10. Cords and sheet of
moderately differentiated and poorly differentiated tumour are seen in
section. C: x2. Pancytokeratin (MNF116) highlighting poorly
differentiated tumour component both superficially and deeply in the fat
of the colon wall (red arrows). D: x4. Pancytokeratin (MNF116)
highlighting tumour cells both superficially and deeply in the fat of the
colon wall.
H&E: hematoxylin and eosin
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FIGURE 6: A: x10, CDX2 uniformly negative in the poorly differentiated
tumour comonent. B: x10. The poorly differentiated tumour cells are
negative with CD68 immunostaining which highlights the tumour
associated macrophages, as indicated by the red arrow. C: x10. The
tumour is completely negative for CK7. D: x10. CK20 Showing patchy
positivity of tumour in the better differentiated superficial aspect of the
tumour. E: x10. CK20 The poorly differentiated aspect of the tumour is
uniformly negative. The sheets of tumour cells are mostly within the red
circled area.
So CK7−/CK20− pattern as seen in the tumour we report is a known phenotype for colorectal cancer, which
is now being shown to be heterogeneous in its molecular profile and therefore patient outcome [5]. CDX2
immunostaining was diffusely positively in the well-differentiated tumour component, while it was negative
in the poorly differentiated component (Figure 7A, 7B). CDX2 is a homeobox gene comparatively specific for
intestinal epithelial tissue [6].
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FIGURE 7: A: x10. CDX2 is uniformly positive in the superficial
well/moderately differentiated aspect of the tumour. B: x10. CDX2. The
poorly differentiated component of the tumour is uniformly negative,
mostly within the marked area. C: x4. MLH1-negative tumour
(well/moderately differentiated area of glandular elements within the red
marked area). D: x4. MLH1 is also diffusely negative in the poorly
differentiated component.
This tumour was shown by immunohistochemistry to be MMR protein deficient (MHL1 & PSM2 negative)
(Figure 7C, 7D, 8A, 8B), but MSH2 (Figure 8C, 8D) and MSH6 (Figure 9A, 9B) positive. The MLH1 promoter
hypermethylation was detected in the tumour-derived DNA component of the sample and within the
spectrum of MSI-H and/or mismatch repair deficient (dMMR by IHC) primary colorectal adenocarcinoma,
and all these results indicate a somatic process. However, these results do not exclude Lynch syndrome in a
patient with a strong family history (Amsterdam II Criteria), in which germline DNA testing may still be
considered necessary. This case is regarded as a de-novo condition as there is no relevant previous family
history; this is significant for the other related family member.
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FIGURE 8: A: x4. PMS2 negative in the well/moderately differentiated
component. B: x10. PMS2 also negative in the poorly differentiated
component. C: x10. MSH2 positive in the well/moderately differentiated
component. D: x10. MSH2 is also positive in the poorly differentiated
component.
FIGURE 9: A: x10. MSH6 is positive in the well/moderately differentiated
component. B: x10. MSH6 is also positive in the poorly differentiated
component.
Discussion
The risk factors for colorectal cancer can be divided into three groups: sporadic, inherited and familial.
Sporadic cases account for 70% of colorectal cancer patients and are due to dietary and environmental
factors. Familial cases with known genetic syndromes make up about 5% of patients and can be divided into
those with/without polyposis, while total inherited cases account for 20-30% of all colorectal cancer patients
[7]. Colorectal cancer commonly presents with changes in bowel habit, abdominal pain/mass, unexplained
rectal bleeding, abdominal distension, iron deficiency anaemia, unintentional weight loss or bowel
obstruction. In Western countries, colorectal cancer is the third most diagnosed malignancy in males and the
second in females and accounts for about 700,000 deaths per year. Most colorectal cancers display
chromosomal instability and the pathogenesis follows the classical adenoma-carcinoma progressive pathway
[8]. However, some colorectal carcinomas originate in non-polypoid colorectal tumours (NPT) with a lateral
spreading growth pattern. These are usually a challenge and difficult to identify at colonoscopy [9]. More
than 90% of colorectal cancer patients are symptomatic at the time of the diagnosis, however this disease
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could also be detected incidentally. Colonic carcinoma may be encountered during screening colonoscopy,
which is offered to people age 55 years and over in the UK. The Danish screening program paper from 2015
revealed that the rate of incidentally detected malignant polyps was 2.3% [3]. It is also reported as an
incidental finding in CT or PET scans being performed for other indications [2]. Incidental large bowel
malignancy also has been noticed during surgery for other causes as in resected inguinal hernia sac,
or during laparotomy for intestinal foreign body [10], and it was also detected in resected bowel after
gunshot injuries [11]. Lee et al. reported that the prevalence of incidental colonic malignancy in autopsy is
about 3% [12]. It has been reported that 10% of patients with colonic ischaemia have an associated large
bowel malignancy, where the ischaemic segment is usually proximal to the tumour and not necessarily
associated with bowel obstruction [13]. The previous reports mentioned that in the larger cancers, the blood
flow in the colonic vessels could be compromised as a consequence of increased intraluminal pressure due to
obstruction, which may result in bowel ischaemia, and this phenomenon is seen in 5% of patients with
ischaemic colitis [14]. In our case, other factors such as sepsis, ischaemic heart disease, vascular disease and
previous abdominal aortic aneurysm may have contributed to the development of bowel ischaemia.
There are three main molecular pathways in the development of colorectal cancers. First is the chromosomal
instability pathway which is involved in up to 80% of colorectal carcinomas. It results from gain of function
mutations which can lead to activation of oncogenes, or decreased activity of tumour suppressor genes.
Mutations in APC and genes that activate the Wnt pathway are included in this pathway. The tumours are
characterized by gross chromosomal abnormalities including deletions, insertions, and loss of
heterozygosity. The second molecular pathogenetic pathway is the microsatellite instability (MSI) pathway
where the presence of microsatellite instability accounts for about 12% of sporadic cases of colorectal
cancers. This is seen with the detection of two or more unstable markers during testing for mismatch repair
deficiency using a polymerase chain reaction (PCR)-based assay, or the detection of the affected protein
gene products by immunohistochemistry for MMR protein products (MLH1, PMS2, MSH2 & MSH6). The
third pathway is the CpG island hypermethylation pathway and was first elucidated in 1999 by Suzuki [15]. It
involves gene promoter-associated CpG islands which are required for controlling transcription. When
hypermethylation of these genes occurs, there is silencing of tumour suppressor genes with occurrence of
tumours showing CpG island hypermethylation phenotype (CIMP). It is an epigenetic-related activity
leading to instability of the CpG islands, hypermethylation of promoter CpG island sites, and the resultant
inactivation of several tumour suppressor genes or other tumour-related genes. Most colorectal carcinomas
with this phenotype present as flat, non-adenomatous mucosal lesions, usually in the right colon, and the
sessile serrated adenomas or polyps represents an example of these lesions which have been associated with
increased risk of developing colorectal carcinomas [16].
Premalignant lesions for colon cancers are local tumours that precede the development of cancers.
Overwhelming evidence points to adenomas and this is referred to as the adenoma-carcinoma sequence. The
adenomas could be polypoid (sessile or pedunculated), flat or depressed lesions of epithelial origin and the
concerning histology feature is dysplasia. Other potential premalignant tumours include hyperplastic
polyps, hamartomatous polyps, aberrant crypt foci and dysplasia in inflammatory bowel disease [17]. The
particular tumour detected in this case report appears to arise from flat or sessile adenoma. The tumour
detected in the colonic specimen was poorly differentiated with deficient MMR (with loss of MLH1 and
PMS2) as detected through immunohistochemistry. In patients with loss of MLH1 staining on IHC, testing
for acquired BRAF mutations and MLH1 promoter hypermethylation is normally done to distinguish
between colorectal cancers that have loss of MLH1 that arise from Lynch syndrome (no MLH1
hypermethylation) and sporadic colorectal cancer caused by epigenetic methylation of MLH1 [18]. Also, in
this tumour, MHL1 promoter hypermethylation was detected, which is consistent with localized epigenetic
inactivation of the MHL1 gene, i.e. sporadic MSI-H colorectal cancer. These sporadic MSI-H colon cancers
often arise in the setting of a specific pathway of DNA hypermethylation, known as the CpG island
methylator phenotype (CIMP), with CIMP-related silencing of MLH1 [19]. Patients with MSI-H tumours have
distinct clinical and pathological features, irrespective of their germline or sporadic origins and these
include proximal colon predominance, frequent poor differentiation and mucinous histology, and increased
number of tumour-infiltrating lymphocytes. In addition to being molecularly distinct from Lynch syndrome
cases, patients with sporadic MSI-H cancers have associated epidemiological features, including older age at
diagnosis, female gender and cigarette smoking [19]. Checking mismatch repair status in patients diagnosed
with colonic cancer helps to give important prognostic and predictive information most especially with
clinical decision making during multidisciplinary meetings. For example, many studies support the view that
adjuvant, single-agent fluoropyrimidine-based chemotherapy is less beneficial, or even potentially harmful,
for patients with MSI-H [20]. In a study in Singapore looking at the prevalence of incidental colorectal
cancer at autopsy and future trends, the tumours were detected in the older population, and this was similar
to the patient in this case report. The majority of the tumours occurred in the ascending colon, similar to our
patient who had the tumour in the ascending colon. Cancers in this location are known to produce
symptoms late in the course of the disease, due to the larger size of the intestinal lumen, and the increased
fluidity of the faecal load. This distribution of incidental tumours in the right colon could also be attributed
to the fact that left colon cancers tend to cause symptoms earlier and are more likely to be detected during
life than right-sided tumours. This has an important significance as the true incidence of right-sided colon
cancers is most likely to be underestimated in the UK [12].
Conclusions
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Colorectal cancer is a common malignancy and not uncommonly asymptomatic. This case presentation
highlights the importance of careful and systematic gross and patho-morphological examination of the non-
cancer bowel specimen as it may harbor early malignancy, especially in higher-risk groups.
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